Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria

/PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced a collaboration with OpenAI that will allow Lilly to leverage OpenAI’s generative AI to invent…
Share This Post
Related Articles
Receive the latest updates

Subscribe To
Our Quarterly Newsletter

Get notified about new blog posts, case studies, white papers, and more!